enoxacin has been researched along with Ovarian Neoplasms in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Not only in melanoma, but also in MCF7 breast carcinoma and A2780 ovarian carcinoma cells overexpressing MdmX." | 1.46 | A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. ( Growkova, K; Mlcochova, J; Radova, L; Slaby, O; Stetkova, M; Uldrijan, S; Valcikova, B; Valianatos, G; Verlande, A; Vyhnakova, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valianatos, G | 1 |
| Valcikova, B | 1 |
| Growkova, K | 1 |
| Verlande, A | 1 |
| Mlcochova, J | 1 |
| Radova, L | 1 |
| Stetkova, M | 1 |
| Vyhnakova, M | 1 |
| Slaby, O | 1 |
| Uldrijan, S | 1 |
1 other study available for enoxacin and Ovarian Neoplasms
| Article | Year |
|---|---|
A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
Topics: Alternative Splicing; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage; | 2017 |